Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525510 · ClinicalTrials.gov registry record · NA
Deceased Organ Donor Interventions to Protect Kidney Graft Function
A NA study of Delayed Graft Function and Brain Death, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,427
- Enrollment target
- 7
- Study locations
NCT02525510: Completed NA study of Delayed Graft Function and Brain Death, sponsored by University of California, San Francisco.
NCT02525510 is a NA study of Delayed Graft Function and Brain Death that has completed, run by University of California, San Francisco. The registered enrollment target is 1,427 participants, above the 137-participant average among 6 other Delayed Graft Function trials with a reported enrollment target (942% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02525510, a NA study of Delayed Graft Function and Brain Death, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,427 participants
- Enrollment target
- 7
- Study locations
Study Summary
To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
Primary Outcome
The incidence of DGF in kidneys from deceased donors enrolled in this trial, obtained from publically available OPTN data.
Conditions Studied
Interventions
- OTHER Pump Eligible - Normothermia - Pump Both Kidneys
- OTHER Pump Eligible - Hypothermia and Pump Right Kidney
- OTHER Pump Eligible - Hypothermia and Pump Left Kidney
- OTHER Not Pump Eligible - Normothermia
- OTHER Not Pump Eligible - Hypothermia
Study Locations (7)
Texas
- Southwest Transplant Alliance - Dallas
- LifeGift - Houston
Arizona
- Donor Network of Arizona - Phoenix
California
- U C San Francisco - San Francisco
Colorado
- Donor Alliance - Denver
Minnesota
- LifeSource - Minneapolis
Oregon
- Pacific Northwest Transplant Bank - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,427 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
What the finished NCT02525510 record still lists
NCT02525510 is an interventional study that assigns participants to a tested intervention. Its 1,427 participants enrollment target places it among the larger protocols in the corpus, above the 137-participant average among 6 other Delayed Graft Function trials with a reported enrollment target (942% higher).
The record links to 4 conditions, with Delayed Graft Function appearing as the primary indexed condition, and to 5 interventions - of which Pump Eligible - Normothermia - Pump Both Kidneys is the first listed.
NCT02525510 lists 7 locations in 6 states (Texas, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT02525510 about?
NCT02525510 is a clinical study titled "Deceased Organ Donor Interventions to Protect Kidney Graft Function". To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
What is the current status of trial NCT02525510?
This trial is currently completed. It is a NA study. The enrollment target is 1,427 participants. The study started on 2017-07-26. Estimated completion is 2022-06-01.
What conditions does trial NCT02525510 study?
This clinical trial studies the following conditions: Delayed Graft Function, Brain Death, Organ Donation, Organ Transplant Failure or Rejection.
What interventions are being tested in trial NCT02525510?
The interventions under investigation include: Pump Eligible - Normothermia - Pump Both Kidneys (OTHER), Pump Eligible - Hypothermia and Pump Right Kidney (OTHER), Pump Eligible - Hypothermia and Pump Left Kidney (OTHER), Not Pump Eligible - Normothermia (OTHER), Not Pump Eligible - Hypothermia (OTHER).
Who is sponsoring clinical trial NCT02525510?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02525510 being conducted?
This trial has 7 study locations across Arizona, California, Colorado, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delayed Graft Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
RECRUITING · Phase 1
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function
ACTIVE NOT RECRUITING · Phase 2
-
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
COMPLETED · Phase 1
-
Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
COMPLETED · Phase 4
-
Envarsus in Delayed Graft Function (E-DGF)
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI